Helical antimicrobial polypeptides with radial amphiphilicity

Proceedings of the National Academy of Sciences of the United States of America

Volumn 112, Issue 43, 2015, Pages 13155-13160

  Xiong, Menghua ^a   Lee, Michelle W ^b   Mansbach, Rachael A ^a   Song, Ziyuan ^a   Bao, Yan ^c   Peek, Richard M ^d   Yao, Catherine ^a   Chen, Lin Feng ^c   Ferguson, Andrew L ^a,e   Wong, Gerard C L ^b   Cheng, Jianjun ^a  

^a University of Illinois at Urbana Champaign   (United States)

^b Engineering IV   (United States)

^c UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Antimicrobial peptide; Bacteria; Polypeptides; Radial amphiphilicity; helix

Indexed keywords

ALPHA HELICAL ANTIMICROBIAL PEPTIDE; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG; ANTIMICROBIAL CATIONIC PEPTIDE;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL MEMBRANE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HYDROPHOBICITY; MEMBRANE DAMAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN STRUCTURE; RADIALLY AMPHIPHILIC STRUCTURE; DRUG EFFECTS; MICROBIAL SENSITIVITY TEST;

ANTIMICROBIAL CATIONIC PEPTIDES; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; MICROBIAL SENSITIVITY TESTS;

EID: 84945539539     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1507893112     Document Type: Article

References (62)

1. Schmidt NW, Wong GC (2013) Antimicrobial peptides and induced membrane curvature: Geometry, coordination chemistry, and molecular engineering. Curr Opin Solid State Mater Sci 17(4):151-163.
2. Yang L, et al. (2008) Mechanism of a prototypical synthetic membrane-active antimicrobial: Efficient hole-punching via interaction with negative intrinsic curvature lipids. Proc Natl Acad Sci USA 105(52):20595-20600.
3. Hurdle JG, O'Neill AJ, Chopra I, Lee RE (2011) Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections. Nat Rev Microbiol 9(1):62-75.
4. Engler AC, et al. (2012) Emerging trends in macromolecular antimicrobials to fight multi-drug-resistant Infections. Nano Today 7(3):201-222.
5. Hancock RE, Sahl HG (2006) Antimicrobial and host-defense peptides as new antiinfective therapeutic strategies. Nat Biotechnol 24(12):1551-1557.
6. Brogden KA (2005) Antimicrobial peptides: Pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 3(3):238-250.
7. Zasloff M (2002) Antimicrobial peptides of multicellular organisms. Nature 415(6870): 389-395.
8. Shai Y (1999) Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membranelytic peptides. Biochim Biophys Acta 1462(1-2):55-70.
9. Breukink E, de Kruijff B (1999) The lantibiotic nisin, a special case or not? Biochim Biophys Acta 1462(1-2):223-234.
10. Matsuzaki K, et al. (1998) Relationship of membrane curvature to the formation of pores by magainin 2. Biochemistry 37(34):11856-11863.
11. Dürr UHN, Sudheendra US, Ramamoorthy A (2006) LL-37, the only human member of the cathelicidin family of antimicrobial peptides. Biochim Biophys Acta 1758(9): 1408-1425.
12. Zasloff M (1987) Magainins, a class of antimicrobial peptides from Xenopus skin: Isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc Natl Acad Sci USA 84(15):5449-5453.
13. Schmidt NW, et al. (2011) Criterion for amino acid composition of defensins and antimicrobial peptides based on geometry of membrane destabilization. J Am Chem Soc 133(17):6720-6727.
14. Lee MW, et al. (2014) Two interdependent mechanisms of antimicrobial activity allow for efficient killing in nylon-3-based polymeric mimics of innate immunity peptides. Biochim Biophys Acta 1838(9):2269-2279.
15. Yang L, et al. (2007) Synthetic antimicrobial oligomers induce a compositiondependent topological transition in membranes. J Am Chem Soc 129(40):12141-12147.
16. Strömstedt AA, Pasupuleti M, Schmidtchen A, Malmsten M (2009) Evaluation of strategies for improving proteolytic resistance of antimicrobial peptides by using variants of EFK17, an internal segment of LL-37. Antimicrob Agents Chemother 53(2): 593-602.
17. Meng H, Kumar K (2007) Antimicrobial activity and protease stability of peptides containing fluorinated amino acids. J Am Chem Soc 129(50):15615-15622.
18. Chen Y, et al. (2005) Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index. J Biol Chem 280(13): 12316-12329.
19. Bahar AA, Ren D (2013) Antimicrobial peptides. Pharmaceuticals (Basel) 6(12): 1543-1575.
20. Hamuro Y, Schneider JP, De Grado WF (1999) De novo design of antibacterial β-peptides. J Am Chem Soc 121(51):12200-12201.
21. Porter EA, Weisblum B, Gellman SH (2002) Mimicry of host-defense peptides by unnatural oligomers: Antimicrobial beta-peptides. J Am Chem Soc 124(25):7324-7330.
22. Porter EA, Wang X, Lee HS, Weisblum B, Gellman SH (2000) Non-haemolytic beta-amino-acid oligomers. Nature 404(6778):565-565.
23. Liu D, De Grado WF (2001) De novo design, synthesis, and characterization of antimicrobial beta-peptides. J Am Chem Soc 123(31):7553-7559.
24. Schmitt MA, Weisblum B, Gellman SH (2007) Interplay among folding, sequence, and lipophilicity in the antibacterial and hemolytic activities of alpha/beta-peptides. J Am Chem Soc 129(2):417-428.
25. Schmitt MA, Weisblum B, Gellman SH (2004) Unexpected relationships between structure and function in alpha, beta-peptides: Antimicrobial foldamers with heterogeneous backbones. J Am Chem Soc 126(22):6848-6849.
26. Patch JA, Barron AE (2003) Helical peptoid mimics of magainin-2 amide. J Am Chem Soc 125(40):12092-12093.
27. Tew GN, et al. (2002) De novo design of biomimetic antimicrobial polymers. Proc Natl Acad Sci USA 99(8):5110-5114.
28. Tew GN, Clements D, Tang H, Arnt L, Scott RW (2006) Antimicrobial activity of an abiotic host defense peptide mimic. Biochim Biophys Acta 1758(9):1387-1392.
29. Tang H, Doerksen RJ, Jones TV, Klein ML, Tew GN (2006) Biomimetic facially amphiphilic antibacterial oligomers with conformationally stiff backbones. Chem Biol 13(4): 427-435.
30. Liu D, et al. (2004) Nontoxic membrane-active antimicrobial arylamide oligomers. Angew Chem Int Ed Engl 43(9):1158-1162.
31. Palermo EF, Sovadinova I, Kuroda K (2009) Structural determinants of antimicrobial activity and biocompatibility in membrane-disrupting methacrylamide random copolymers. Biomacromolecules 10(11):3098-3107.
32. Mowery BP, Lindner AH, Weisblum B, Stahl SS, Gellman SH (2009) Structure-activity relationships among random nylon-3 copolymers that mimic antibacterial hostdefense peptides. J Am Chem Soc 131(28):9735-9745.
33. Mowery BP, et al. (2007) Mimicry of antimicrobial host-defense peptides by random copolymers. J Am Chem Soc 129(50):15474-15476.
34. Liu R, et al. (2013) Nylon-3 polymers with selective antifungal activity. J Am Chem Soc 135(14):5270-5273.
35. Liu R, et al. (2014) Structure-activity relationships among antifungal nylon-3 polymers: Identification of materials active against drug-resistant strains of Candida albicans. J Am Chem Soc 136(11):4333-4342.
36. Zhou C, et al. (2010) High potency and broad-spectrum antimicrobial peptides synthesized via ring-opening polymerization of alpha-aminoacid-N-carboxyanhydrides. Biomacromolecules 11(1):60-67.
37. Engler AC, et al. (2011) Effects of side group functionality and molecular weight on the activity of synthetic antimicrobial polypeptides. Biomacromolecules 12(5): 1666-1674.
38. Chin W, et al. (2013) Biodegradable broad-spectrum antimicrobial polycarbonates: Investigating the role of chemical structure on activity and selectivity. Macromolecules 46(22):8797-8807.
39. Gabriel GJ, et al. (2009) Comparison of facially amphiphilic versus segregated monomers in the design of antibacterial copolymers. Chemistry 15(2):433-439.
40. Colak S, Nelson CF, Nüsslein K, Tew GN (2009) Hydrophilic modifications of an amphiphilic polynorbornene and the effects on its hemolytic and antibacterial activity. Biomacromolecules 10(2):353-359.
41. Ng VW, Ke X, Lee AL, Hedrick JL, Yang YY (2013) Synergistic co-delivery of membrane-disrupting polymers with commercial antibiotics against highly opportunistic bacteria. Adv Mater 25(46):6730-6736.
42. Nederberg F, et al. (2011) Biodegradable nanostructures with selective lysis of microbial membranes. Nat Chem 3(5):409-414.
43. Yin L, et al. (2013) Supramolecular self-assembled nanoparticles mediate oral delivery of therapeutic TNF-α siRNA against systemic inflammation. Angew Chem Int Ed Engl 52(22):5757-5761.
44. Lu H, et al. (2011) Ionic polypeptides with unusual helical stability. Nat Commun 2:206.
45. Gabrielson NP, et al. (2012) Reactive and bioactive cationic α-helical polypeptide template for nonviral gene delivery. Angew Chem Int Ed Engl 51(5):1143-1147.
46. Lu H, Cheng J (2007) Hexamethyldisilazane-mediated controlled polymerization of alpha-amino acid N-carboxyanhydrides. J Am Chem Soc 129(46):14114-14115.
47. Bulheller BM, Hirst JD (2009) Dichro Calc-circular and linear dichroism online. Bioinformatics 25(4):539-540.
48. (2014) MATLAB (The MathWorks, Natick, MA).
49. Andrews JM (2002) Determination of minimum inhibitory concentrations. J Antimicrob Chemother 49(6):1049-1050.
50. Peek RM, Jr, et al. (1999) Helicobacter pylori strain-specific genotypes and modulation of the gastric epithelial cell cycle. Cancer Res 59(24):6124-6131.
51. Israel DA, et al. (2001) Helicobacter pylori genetic diversity within the gastric niche of a single human host. Proc Natl Acad Sci USA 98(25):14625-14630.
52. Findlay B, Zhanel GG, Schweizer F (2010) Cationic amphiphiles, a new generation of antimicrobials inspired by the natural antimicrobial peptide scaffold. Antimicrob Agents Chemother 54(10):4049-4058.
53. Brogden NK, Brogden KA (2011) Will new generations of modified antimicrobial peptides improve their potential as pharmaceuticals? Int J Antimicrob Agents 38(3): 217-225.
54. Hu K, et al. (2013) A critical evaluation of random copolymer mimesis of homogeneous antimicrobial peptides. Macromolecules 46(5):1908-1915.
55. Eckert R, et al. (2006) Enhancement of antimicrobial activity against pseudomonas aeruginosa by coadministration of G10KHc and tobramycin. Antimicrob Agents Chemother 50(11):3833-3838.
56. Boucrot E, et al. (2012) Membrane fission is promoted by insertion of amphipathic helices and is restricted by crescent BAR domains. Cell 149(1):124-136.
57. Schmidt NW, Mishra A, Wang J, De Grado WF, Wong GC (2013) Influenza virus A M2 protein generates negative Gaussian membrane curvature necessary for budding and scission. J Am Chem Soc 135(37):13710-13719.
58. Schmidtchen A, et al. (2011) Membrane selectivity by W-tagging of antimicrobial peptides. Biochim Biophys Acta 1808(4):1081-1091.
59. Ringstad L, et al. (2008) An electrochemical study into the interaction between complement-derived peptides and DOPC mono- and bilayers. Langmuir 24(1): 208-216.
60. Bechinger B (1999) The structure, dynamics and orientation of antimicrobial peptides in membranes by multidimensional solid-state NMR spectroscopy. Biochim Biophys Acta 1462(1-2):157-183.
61. García-Sáez AJ, Chiantia S, Salgado J, Schwille P (2007) Pore formation by a Bax-derived peptide: Effect on the line tension of the membrane probed by AFM. Biophys J 93(1): 103-112.
62. Mansbach RA, Ferguson AL (2015) Machine learning of single molecule free energy surfaces and the impact of chemistry and environment upon structure and dynamics. J Chem Phys 142(10):105101.